News

2016 May 12

The broad spectrum of myelodysplastic syndrome

Ellen Ritchie, M.D., discusses the current best practices in the management of myelodysplastic syndromes and how the latest research is likely to impact the field. Read more

Photo of Drs. Rubin, Sboner, Beltran and Elemento

2016 May 12

Genomic data sharing expands possibilities of precision medicine

The Englander Institute for Precision Medicine has formed a new partnership with Australia's Garvan Institute. Read more

2016 May 12

An old idea, revived: Starve cancer to death

Lewis Cantley, Ph.D., discusses the "rather scary" influence of sugar and insulin on cancer. Read more

2016 May 10

Women Who Use Their Bodies For Work

Surgeon Tracy-Ann Moo, M.D., is featured in a photo series about women at work. Read more

2016 May 09

Cantley becomes Hope Funds honoree

Lewis Cantley, Ph.D., is one of four recipients of a Hope Funds 2016 Award of Excellence. Read more

2016 May 08

Ovarian cancer survivor says her pregnancy 'saved' her life

Kevin Holcomb, M.D., discusses symptoms of ovarian cancer that are often ignored. Read more

2016 May 05

Cancer is a low-down, dirty gangster ninja

Harold Varmus, M.D., discusses the dynamic nature of cancer and why it is such a difficult series of diseases to treat. Read more

2016 May 05

Prostate cancer screening guidelines called into question

Jim Hu, M.D., has questioned the results of a large-scale clinical trial assessing the value of PSA screening that served as the basis for national screening guidelines. Read more

2016 May 04

Mason awarded Pershing Square Sohn Cancer Research prize

Christopher Mason, Ph.D., is one of seven researchers to receive the Young Investigators in Cancer Research prize. Read more

2016 May 02

MDx for Prostate Cancer

Mark Rubin, M.D., discusses the importance of biomarkers to distinguish indolent from aggressive cancer. Read more

2016 Apr 28

Advantages with Whole-Exome Sequencing

Mark A. Rubin, M.D., talks to OncLive about the advantages of whole-exome sequencing and how it compares with targeted sequencing. Read more

2016 Apr 28

At the crossroads in surgical education

Heather Yeo, MD, MHS, assistant professor of surgery and assistant professor of public health, wrote a guest post on the Association of Women Surgeons blog. Read the original here . Dr. Heather Yeo and her father. Over the... Read more

2016 Apr 27

7 Signs of Ovarian Cancer You Might Be Ignoring

Kevin Holcomb, M.D., discusses some of the "silent" symptoms of ovarian cancer. Read more

2016 Apr 26

What the gut? Two studies explore microbiome-cancer connection

Teams at Weill Cornell Medicine are exploring the complex workings of the gastrointestinal microbiota and metabolome. Read more

Monica Guzman, Ph.D., is combatting leukemia using CAR-T immunotherapy

2016 Apr 25

Cranberry compound packs powerful cancer punch

A compound made from cranberries has shown promise in killing several leukemia cell lines and blood samples from acute myelogenous leukemia (AML) patients. Read more

Michael Albert, 17, helped ID a potential drug target to treat acute myeloid leukemia

2016 Apr 25

Teenager helps ID new target for aggressive leukemia

Michael Albert, 17, has worked with the lab of Monica Guzman, Ph.D., to identify ephrin receptors as potential therapeutic targets for acute myeloid leukemia. Read more

2016 Apr 25

Drug developed for lymphoma could provide hope for lung cancer patients

The lab of Leandro Cerchietti, M.D., has revealed early evidence that a BCL6 inhibitor initially studied as a potential B-cell lymphoma treatment might also be effective against chemo-resistant non-small cell lung cancers. Read more

2016 Apr 21

Questions on PD-L1 Diagnostics for Immunotherapy in NSCLC

Brendon Stiles, M.D., comments on the immunotherapies available to treat non-small cell lung cancer. Read more

Gastrointestinal oncologist Allyson Ocean of the Meyer Cancer Center

2016 Apr 21

10 Things Cancer Experts Do To Avoid Getting The Disease

Allyson Ocean, M.D., shares some pointers with Prevention Magazine. Read more

2016 Apr 20

Copper depletion may reduce breast cancer relapse in patients at high risk

Linda Vahdat, M.D., shares results of studies into copper depletion as a potential therapy for triple-negative breast cancer. Read more

News

The broad spectrum of myelodysplastic syndrome

Genomic data sharing expands possibilities of precision medicine

An old idea, revived: Starve cancer to death

Women Who Use Their Bodies For Work

Cantley becomes Hope Funds honoree

Ovarian cancer survivor says her pregnancy 'saved' her life

Cancer is a low-down, dirty gangster ninja

Prostate cancer screening guidelines called into question

Mason awarded Pershing Square Sohn Cancer Research prize

MDx for Prostate Cancer

Advantages with Whole-Exome Sequencing

At the crossroads in surgical education

7 Signs of Ovarian Cancer You Might Be Ignoring

What the gut? Two studies explore microbiome-cancer connection

Cranberry compound packs powerful cancer punch

Teenager helps ID new target for aggressive leukemia

Drug developed for lymphoma could provide hope for lung cancer patients

Questions on PD-L1 Diagnostics for Immunotherapy in NSCLC

10 Things Cancer Experts Do To Avoid Getting The Disease

Copper depletion may reduce breast cancer relapse in patients at high risk

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters